Health system strengthening and hypertension management in China

Global Health Research and Policy

Volumn 1, Issue 1, 2016, Pages

  Huang, Kehui ^a   Song, Yu Ting ^a   He, Yong Huan ^a   Feng, Xing Lin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

China; Health system; Hypertension management

Indexed keywords

EID: 85019672634     PISSN: None     EISSN: 23970642     Source Type: Journal    
DOI: 10.1186/s41256-016-0013-8     Document Type: Review

References (42)

1. WHO. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
2. Lozano R, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128. DOI: 10.1016/S0140-6736(12)61728-0
3. UN General Assembly. Political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. New York: United Nations; 2011.
4. Lewington S, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13. DOI: 10.1016/S0140-6736(02)11911-8
5. Lim SS, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60. DOI: 10.1016/S0140-6736(12)61766-8
6. WHO. A global brief on hypertension-silent killer, global public health crisis. 2013.
7. Mendis S, et al. Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ. 2010;88(6):412–9. DOI: 10.2471/BLT.08.062364
8. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611–9. DOI: 10.1016/S0140-6736(12)60861-7
9. James PA, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20. DOI: 10.1001/jama.2013.284427
10. Xu W, et al. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. BMJ. 2015;350:h158. DOI: 10.1136/bmj.h158
11. WHO. Everybody’s business: Strengthening health systems to improve health outcomes: WHO’s framework for action. Geneva: World Health Organization; 2007.
12. Maimaris W, et al. The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review. PLoS Med. 2013;10(7):e1001490. DOI: 10.1371/journal.pmed.1001490
13. Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014;92(1):29–41. DOI: 10.2471/BLT.13.124495
14. He J, et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet. 2009;374(9703):1765–72. DOI: 10.1016/S0140-6736(09)61199-5
15. WHO. Monitoring the building blocks of health systems. 2010.
16. WHO. Checklist and Indicators for Monitoring Progress in the Development of IHR Core Capacities in States Parties. 2005.
17. Gu D, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in China. Hypertension. 2002;40(6):920–7. DOI: 10.1161/01.HYP.0000040263.94619.D5
18. Reynolds K, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21(7):1273–81. DOI: 10.1097/00004872-200307000-00014
19. Dong G, et al. Prevalence, awareness, treatment, and control of hypertension in rural adults from Liaoning Province, northeast China. Hypertens Res. 2007;30(10):951–8. DOI: 10.1291/hypres.30.951
20. Li H, et al. Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province. J Hypertens. 2010;28(3):432–8. DOI: 10.1097/HJH.0b013e328334b39e
21. Li D, et al. Hypertension burden and control in mainland China: Analysis of nationwide data 2003–2012. Int J Cardiol. 2015;184:637–44. DOI: 10.1016/j.ijcard.2015.03.045
22. Guo J, et al. The dynamics of hypertension prevalence, awareness, treatment, control and associated factors in Chinese adults. J Hypertens. 2015;33(8):1688–96. DOI: 10.1097/HJH.0000000000000594
23. Basu S, Millett C. Social Epidemiology of Hypertension in Middle-Income Countries: Determinants of Prevalence, Diagnosis, Treatment, and Control in the WHO SAGE Study. Hypertension. 2013;62(1):18–26. DOI: 10.1161/HYPERTENSIONAHA.113.01374
24. Lloyd-Sherlock P, et al. Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014;43(1):116–28. DOI: 10.1093/ije/dyt215
25. Wang J, et al. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27(11):1355–61. DOI: 10.1093/ajh/hpu053
26. Bi Z, et al. Hypertension prevalence, awareness, treatment, and control and sodium intake in Shandong Province, China: baseline results from Shandong-Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011. Prev Chronic Dis. 2014;11:E88. DOI: 10.5888/pcd11.130423
27. Wang H, et al. Factors associated with prevalence, awareness, treatment and control of hypertension among adults in Southern China: a community-based, cross-sectional survey. PLoS One. 2013;8(5):e62469. DOI: 10.1371/journal.pone.0062469
28. Zhang J, et al. Prevalence, awareness, medication, control, and risk factors associated with hypertension in Bai ethnic group in rural China: the Yunnan Minority Eye Study. PLoS One. 2013;8(8):e70886. DOI: 10.1371/journal.pone.0070886
29. Zhao Y, et al. Trends in population blood pressure and prevalence, awareness, treatment, and control of hypertension among middle-aged and older adults in a rural area of Northwest China from 1982 to 2010. PLoS One. 2013;8(4):e61779. DOI: 10.1371/journal.pone.0061779
30. Hou Z, Meng Q, Zhang Y. Hypertension Prevalence, Awareness, Treatment, and Control Following China’s Healthcare Reform. Am J Hypertens. 2015;29(4):428–31. DOI: 10.1093/ajh/hpv125
31. Zeng XY, et al. The study of management of hypertensive people aged 35 and over in communities in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2013;47(11):1014–9.
32. Department, H. National essential public health services (2009). 2009. p. 1.
33. Wong MCS. Performance Comparison among the Major Healthcare Financing Systems in Six Cities of the Pearl River Delta Region, Mainland China. PLOS ONE. 2012;7(9):1–3.
34. WHO. Prevention of Cardiovascular Disease. 2007.
35. WHO. Integrated Management of Cardiovascular Risk. 2002.
36. Liu L. Guidelines for prevention and treatment of hypertension in China. Chin J Hypertens. 2011;19(8):701–43.
37. Wang Z, Wang X, Zhang L. Community hypertension control: evaluation of the effect of blood pressure management. Chin J Epidemiol. 2010;31(1):1–4.
38. Li G. Effects of Guideline-based Hypertension Management in Rural Areas of Guangdong Province. Chin Med J. 2015;128(6):799–803. DOI: 10.4103/0366-6999.152485
39. Lu C, et al. Community-based interventions in hypertensive patients: a comparison of three health education strategies. BMC Public Health. 2015;15(1):33. DOI: 10.1186/s12889-015-1401-6
40. Yun R, Yan LL. Effectiveness of a Community-Based Individualized Lifestyle Intervention Among Older Adults With Diabetes and Hypertension, Tianjin, China, 2008–2009. Prev Chronic Dis. 2014;11:1–7.
41. Niu H, et al. Differences and determinants in access to essential public health services in China: a case study with hypertension people and under-sixes as target population. Chin Med J (Engl). 2014;127(9):1626–32.
42. Gu D, et al. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study. PLoS Med. 2015;12(8):e1001860. DOI: 10.1371/journal.pmed.1001860